CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Beijing Beilu Pharmaceutical Company Limited Company Snapshot
Beijing Beilu Pharmaceutical Company Limited operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Beilu Pharmaceutical Company Limited with three other companies in this sector in CHINA : PharmaBlock Sciences Nanjing Inc (2019 sales of 662.23 million Chinese Renmimbi [US$100.55 million] of which 73% was Above kg class), Kingworld Medicines Group Limited (977.93 million Chinese Renmimbi [US$148.49 million] of which 91% was Distribution sales of pharmaceutical and), and GuangYuYuan Chinese Herbal Medicine Co Ltd (1.21 billion Chinese Renmimbi [US$184.32 million] of which 87% was Drug Industry).

Sales Analysis. Beijing Beilu Pharmaceutical Company Limited reported sales of 819.12 million Chinese Renmimbi (US$124.38 million) for the year ending December of 2019. This represents an increase of 34.7% versus 2018, when the company's sales were 608.05 million Chinese Renmimbi. Sales at Beijing Beilu Pharmaceutical Company Limited have increased during each of the previous five years (and since 2014, sales have increased a total of 86%). Sales of Pharmaceutical Sales saw an increase of 35.3% in 2019, from 605.55 million Chinese Renmimbi to 819.11 million Chinese Renmimbi. Not all segments of Beijing Beilu Pharmaceutical Company Limited experienced an increase in sales in 2019: sales of Other Operation fell 99.5% to 11,320.75 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Beijing Beilu Pharmaceutical Company Limited
  Stock Performance Chart for Beijing Beilu Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 11.59
(Figures in Chinese Renmimbi)
1 Week 3.3%   13 Weeks 4.7%  
4 Weeks -4.1%   52 Weeks 38.8%  
 
Beijing Beilu Pharmaceutical Company Limited Key Data:
  Ticker: 300016 Country: China
  Exchanges: SZN Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2019 Sales 819,119,390
(Year Ending Jan 2020).
Employees: 641
  Currency: Chinese Renmimbi Market Cap: 5,730,317,091
  Fiscal Yr Ends: December Shares Outstanding: 494,419,076
  Share Type: A Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.